UMIN-CTR Clinical Trial

Recruitment status Enrolling by invitation
Unique ID issued by UMIN UMIN000045117
Receipt No. R000051541
Scientific Title The survey of motor ability for the people who had been infected with COVID-19
Date of disclosure of the study information 2021/08/11
Last modified on 2022/02/21 (Ver. 2)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title The survey of motor ability for the people who had been infected with COVID-19
Acronym The survey of motor ability for the patients with COVID-19
Scientific Title The survey of motor ability for the people who had been infected with COVID-19
Scientific Title:Acronym The survey of motor ability for the patients with COVID-19
Region
Japan

Condition
Condition COVID-19 infection
Classification by specialty
Medicine in general Orthopedics
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To investigate whether patients been infected with COVID-19 have prolonged locomotor dysfunction or persistent musculoskeletal pain, and find the relationship with the status of return to social life
Basic objectives2 Others
Basic objectives -Others The related factors for prolonged locomotor dysfunction
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes The prevalence of locomotive syndrome and the severity
Key secondary outcomes persistent musculoskeletal pain, the status of return to social life (work, school, sports)

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit
84 years-old >=
Gender Male and Female
Key inclusion criteria The patients who had been finished the treatment for COVID-19 and discharged over two months before
Key exclusion criteria The patients who do not agree with the prescribed opt-out
The patients who are in postoperative acute phase and hard to receive telephone-based medicine
Target sample size 800

Research contact person
Name of lead principal investigator
1st name Akira
Middle name
Last name Sakawa
Organization Osaka City Juso Hospital
Division name Department of Orthopedic surgery
Zip code 5320034
Address 2-12-27, Nonakakita, Yodogawa-ku, Osaka, Japan
TEL 0661508000
Email Akirasakawa@aol.com

Public contact
Name of contact person
1st name Kazunori
Middle name
Last name Hayashi
Organization Osaka City Juso Hospital
Division name Department of Orthopedic surgery
Zip code 5320034
Address 2-12-27, Nonakakita, Yodogawa-ku, Osaka, Japan
TEL 0661508000
Homepage URL
Email kh_ocg@yahoo.co.jp

Sponsor
Institute Osaka City Juso Hospital
Institute
Department

Funding Source
Organization None
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Osaka City Juso Hospital
Address 2-12-27, Nonakakita, Yodogawa-ku, Osaka, Japan
Tel 0661508000
Email close to public

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions 大阪市立十三市民病院

Other administrative information
Date of disclosure of the study information
2021 Year 08 Month 11 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Enrolling by invitation
Date of protocol fixation
2021 Year 08 Month 06 Day
Date of IRB
2021 Year 08 Month 06 Day
Anticipated trial start date
2021 Year 08 Month 06 Day
Last follow-up date
2022 Year 07 Month 31 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information The survey is conducted by questionnaire

Management information
Registered date
2021 Year 08 Month 10 Day
Last modified on
2022 Year 02 Month 21 Day


Link to view the page
URL(English) https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000051541